Home Tags TNBC

Tag: TNBC

New Therapy Targets Aggressive Chemotherapy-Resistant Breast Cancer

Scientists have identified a new multi-kinase inhibitor that targets breast cancer stem cells in chemotherapy-resistant triple negative breast cancer. TNBC disproportionately affects younger, premenopausal women, women with inherited mutations in the BRCA1 gene, and Black women. The new therapy holds the potential to improve survival and quality of life for patients diagnosed with triple negative breast cancer who are currently treated with a combination of radiation and chemotherapy that is largely ineffective.